RecruitingPhase 2Phase 3NCT04724252

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children


Sponsor

University of California, Davis

Enrollment

60 participants

Start Date

Aug 23, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin


Eligibility

Max Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Gabapentin and Placebo for people with pain, postoperative. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGabapentin

Determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after surgery.

OTHERPlacebo

Control Arm


Locations(1)

UC Davis Medical Center

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04724252


Related Trials